Corifact Kit
Product Images NDC 63833-518

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Corifact (NDC 63833-518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Corifact 01)

FDA Label Image

Figure 2 (Corifact 02)

FDA Label Image

Figure 3 (Corifact 03)

FDA Label Image

Figure 4 (Corifact 04)

FDA Label Image

Figure 5 (Corifact 05)

FDA Label Image

Figure 6 (Corifact 06)

FDA Label Image

Figure 7 (Corifact 07)

FDA Label Image

Figure 8 (Corifact 08)

FDA Label Image

Principal Display Panel (1000-1600 IU Vial Label)

Principal Display Panel (1000-1600 IU Vial Label)
Corifact® is a Factor XIII Concentrate used intravenously for reconstituted solution. The single-dose vial contains 1000-1600 International Units(units) of ophilized Facto Xl concentrate. It should be stored in a refrigerator at 2-8°C (36~46°F) and protected from light. Corifact® is stable for 36 months, up to the expiration date on the cartridge and vial labels. However, it should not be used if the reconstituted solution is cloudy or contains particles, nor should it be frozen. Only use the product for intravenous use. The information has a manufacturer name in Germany and a distributor name in Kankakes.*
FDA Label Image

Principal Display Panel (Kit Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.